Marina Nikolic
Overview
Explore the profile of Marina Nikolic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
479
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Muric M, Srejovic I, Novakovic J, Zivkovic V, Jovic J, Sretenovic J, et al.
Cardiovasc Drugs Ther
. 2025 Feb;
PMID: 39913081
Purpose: The idea behind this study was to assess the effects of empagliflozin and sacubitril/valsartan and their combination on isoproterenol-induced heart failure (HF) and underlying molecular mechanisms. Methods: HF was...
2.
Corbic M, Jakovljevic V, Nikolic M, Jeremic N, Bradic J, Novakovic J, et al.
Mol Cell Biochem
. 2025 Feb;
PMID: 39894905
Psoriasis has been considered a systemic immune-mediated disease that can affect function of the heart. However, certain herbal therapy approaches may nullify side effects of psoriasis on the heart. The...
3.
Nikolic M, Delak L, Arbanas J, Celic crnac T
Acta Med Hist Adriat
. 2024 Nov;
22(1):139-161.
PMID: 39580655
Anatomy is a dynamic and translational discipline that integrates research and education. Throughout the centuries, anatomical knowledge has become increasingly important for the medical sciences, especially surgery. Cadaver dissection remains...
4.
Nikolic M, Eisner C, Neumann J, Haux D, Krieg S, Wielputz M, et al.
BMC Anesthesiol
. 2024 Oct;
24(1):375.
PMID: 39415125
Background: Neurosurgery performed in the semi-sitting position provides advantages for certain procedures. However, this approach is associated with potential complications, particularly venous air embolism. Due to typically negative venous pressure...
5.
Ordashev K, Milojevic Samanovic A, Omarov I, Zivkovic V, Nikolic Turnic T, Novakovic J, et al.
Arch Oral Biol
. 2024 Sep;
169:106089.
PMID: 39255649
Objective: To evaluate the possible effects of apical periodontitis (AP) on cardiac function, structure, and oxidative stress (OS) in rats with diabetes mellitus type 2 (T2DM). Design: Forty-eight (Wistar albino,...
6.
Muric M, Nikolic M, Todorovic A, Jakovljevic V, Vucicevic K
Biomolecules
. 2024 Aug;
14(8).
PMID: 39199344
The use of non-vitamin K antagonist oral anticoagulants (NOACs) has brought a significant progress in the management of cardiovascular diseases, considered clinically superior to vitamin K antagonists (VKAs) particularly in...
7.
Rudic T, Stojanovic A, Sobot N, Novakovic J, Bolevich S, Bolevich S, et al.
Mol Cell Biochem
. 2024 Aug;
480(3):1747-1762.
PMID: 39187740
Cardiovascular diseases remains leading cause of death and disabilities. Coronary artery occlusion and consequent ischemia leads to acute myocardial infarction, but restoration of blood flow, paradoxically, provokes further myocardial damage...
8.
Stojkovic M, Jovanovic M, Jakovljevic V, Zivkovic V, Djordjevic N, Kocovic A, et al.
Biomedicines
. 2024 Jul;
12(7).
PMID: 39061992
Several studies indicate the impact of antipsychotics like risperidone and paliperidone on oxidative stress parameters, yet data remain inconsistent. We investigated the link between these medications, hyperprolactinemia (HPRL), and oxidative...
9.
Ravic M, Srejovic I, Novakovic J, Andjic M, Sretenovic J, Muric M, et al.
Pharmaceuticals (Basel)
. 2024 Apr;
17(4).
PMID: 38675485
Metabolic syndrome (MetS) represents an important factor that increases the risk of myocardial infarction, and more severe complications. Glucagon Like Peptide-1 Receptor Agonists (GLP-1RAs) exhibit cardioprotective potential, but their efficacy...
10.
Nikolic M, Jeremic N, Lazarevic N, Stojanovic A, Milojevic Samanovic A, Novakovic J, et al.
Biofactors
. 2024 Jan;
50(4):772-793.
PMID: 38284316
In addition to their usual use in the treatment of cardiovascular disease, weak evidence is available for the potential of combined use of neprilysin inhibitor (sacubitril) and AT1 receptor antagonist...